ANLAdlai Nortye Ltd.
$15.50+796% 1Y
$15.50
$0.8852 weeks$16.60
ANL as reported
- Net income
- −$52M
Net income · −53% year on year · trailing twelve months to FY2024
- Free cash flow
- −$52M
Free cash flow · −8.6% year on year · trailing twelve months to FY2024
- EPS
- −$0.54
EPS · −79% year on year · trailing twelve months to FY2024
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$52M | −53% | FY2024 |
| EPS | −$0.54 | −79% | FY2024 |
| ROE | −204% | n/a | FY2024 |
| ROA | −73% | n/a | FY2024 |
| ROIC | −243% | n/a | FY2024 |
| Free cash flow | −$52M | −8.6% | FY2024 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Adlai Nortye Ltd. (ANL) · Net incomeNet incomeAdlai Nortye Ltd. (ANL)
Biotechnology
The closest names by size in the same industry